🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

up bright and early to hear Michael Rybak, Dr. Jennifer Le, and Dr. Tom Lodise to go through the new #vancomycin guidelines at #ASHP19

Thread on ASHP Midyear presentation for soon-to-be-released #vancomycin guidelines #ASHP19

Today is the day! If you can’t make it in person, join the webinar to hear rockstars Erin McCreary and Sam Aitken share their clinical experience and insights on managing MDR GNR infections!

👇🏻 My attempt at live tweeting the live session and live streaming session 🤣 from Erin McCreary Erin McCreary and Sam Aitken Sam Aitken session at ASHP #ASHP19 on resistant Gram negative infections/agents.

Big day today for first year Med students at Pitt, they got to hear Erin McCreary drop some incredibly useful PK applications that connect basic pharmacology to the clinic. It was awesome! #startemyoung ID Pitt Stop

Abstract notifications are sent out. If you don't have yours yet, be patient...the server is working hard to process all those emails. For your convenience, this year we sent mails to the submitter and the presenting author as well!

Getting ready to kick off the AMR and stewardship conference in Houston chaired by Cesar Arias with a phenomenal agenda: gccamrjan2020.blogs.rice.edu. Can’t wait! #AMRHouston2020

CRACKLE-2 data coming soon in The Lancet Infectious Diseases over 1,000 patients with CRE!!! David van Duin #AMRHouston2020

Wow! A surprising and unexpected finding from CRACKLE-2. Outcomes very similar for CPE and non-CPE infected patients! Same for unconfirmed CRE by phenotype 👀More to come in The Lancet Infectious Diseases publication by David van Duin Cesar Arias et al. #AMRHouston2020

If you want a detailed review of treatment options, this is your source! 👇

#AACJournal launches a new section: New Perspectives on Antimicrobial Agents, Edited by Ryan Shields . Our first paper focuses on Remdesevir!

Great speakers for our upcoming TDM workshop and will be available for viewing on @CRE_REDUCE YouTube channel afterwards 👍Paul Williams Kathryn Daveson hfzaziz Darren Roberts 🇦🇺🏳️‍🌈 @GweeAmanda John Turnidge @SuzieParker_CMG Jan J De Waele UQ Medicine UQ Health

Launching the new AAC section in grand fashion! Stay tuned for more great content coming soon!

Hot off the press #AACJournal. Real world assesment of ceftolozane/tazobactam resistance in P. aeruginosa during therapy and its impact in other B-lactam/B-lactam inhibitors ASM, Ryan Shields, Antibacterial Resistance Leadership Group David van Duin . aac.asm.org/content/early/…

Kudos to Abigail Rubio and our fantastic co-authors Daria Van Tyne Vaughn Cooper (see: vscooper@bsky) Neil Clancy [email protected] @cleverwebber. C/T resistance most commonly mediated by ampC mutations leading to structural modifications, cross-R to CZA, and increased susceptibility to imipenem ID Pitt Stop

When you finish enrollment into a prospective beta-lactam TDM study as an ID fellow you get a cake and balloons! Congrats to B. Smith and a huge thanks to the research team ID Pitt Stop ! Stay tuned for some really cool data in the months ahead....😎

#AACJournal podcast in Editors in Conversation series ASM now available! A great discussion with @pranita_tamma and Dr. Robert Bonomo on B-lactam/B-lactamase inhibitors. Antibacterial Resistance Leadership Group asm.org/Podcasts/Edito…

Hot-off-the-press #AACJournal. Our latest article in the New Perspectives on Antimicrobial Agents section edited by Ryan Shields . The focus is Cefiderocol written by a team of experts Erin McCreary @pranita_tamma ASM Antibacterial Resistance Leadership Group aac.asm.org/content/early/…